What you need to know about PEG immunogenicity

PEGylation is a breakthrough technique to improve drug delivery systems, but it also has a downside: it can trigger immune reactions that reduce drug efficacy and safety. Designed for R&D leaders, this idea in brief shows how we can overcome this challenge. It summarizes the latest trends and opportunities, PEG-lipid structure, LNP composition and properties, and which pharmaceutical parameters affect their immunogenicity and efficiency. Learn more and share with your network:

INSGENENGWHP101133-CAS-Insights-PEGylated-LNPs-Fanned-Image

Download the executive summary

Related CAS Insights

新興の科学分野

16 billion reasons for hope: How biomarkers are reshaping cancer outcomes

March 20, 2024

Read article
新興の科学分野

2023年最大の科学のブレークスルーと最新トレンド

January 31, 2023

Read article
新興の科学分野

Aging reimagined: Exploring the potential of anti-aging treatment strategies

July 21, 2023

Read article

Gain new perspectives for faster progress directly to your inbox.